Dataset Information

Fast Delayed Emission in New Pyridazine-Based Compounds.

ABSTRACT: Three novel donor-acceptor molecules comprising the underexplored pyridazine (Pydz) acceptor moiety have been synthesized and their structural, electrochemical and photophysical properties thoroughly characterized. Combining Pydz with two phenoxazine donor units linked via a phenyl bridge in a meta configuration (dPXZMePydz) leads to high reverse intersystem crossing rate k _RISC = 3.9 · 10⁶ s^-1 and fast thermally activated delayed fluorescence (TADF) with <500 ns delayed emission lifetime. Efficient triplet harvesting via the TADF mechanism is demonstrated in OLEDs using dPXZMePydz as the emitter but does not occur for compounds bearing weaker donor units.

SUBMITTER: Krotkus S

PROVIDER: S-EPMC7817954 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Fast Delayed Emission in New Pyridazine-Based Compounds.

Krotkus Simonas S Matulaitis Tomas T Diesing Stefan S Copley Graeme G Archer Emily E Keum Changmin C Cordes David B DB Slawin Alexandra M Z AMZ Gather Malte C MC Zysman-Colman Eli E Samuel Ifor D W IDW

Frontiers in chemistry 20210107

Three novel donor-acceptor molecules comprising the underexplored pyridazine (Pydz) acceptor moiety have been synthesized and their structural, electrochemical and photophysical properties thoroughly characterized. Combining Pydz with two phenoxazine donor units linked via a phenyl bridge in a meta configuration (dPXZMePydz) leads to high reverse intersystem crossing rate k RISC = 3.9 · 106 s-1 and fast thermally activated delayed fluorescenc ...[more]

PMID: 33490031

Similar Datasets

Project description:The conventional battery for genotoxicity testing is not well suited to assessing the large number of chemicals needing evaluation. Traditional in vitro tests lack throughput, provide little mechanistic information, and have poor specificity in predicting in vivo genotoxicity. New Approach Methodologies (NAMs) aim to accelerate the pace of hazard assessment and reduce reliance on in vivo tests that are time-consuming and resource-intensive. As such, high-throughput transcriptomic and flow cytometry-based assays have been developed for modernized in vitro genotoxicity assessment. This includes: the TGx-DDI transcriptomic biomarker (i.e., 64-gene expression signature to identify DNA damage-inducing (DDI) substances), the MicroFlow® assay (i.e., a flow cytometry-based micronucleus (MN) test), and the MultiFlow® assay (i.e., a multiplexed flow cytometry-based reporter assay that yields mode-of-action (MoA) information). The objective of this study was to investigate the utility of the TGx-DDI transcriptomic biomarker, multiplexed with the MicroFlow® and MultiFlow® assays, as an integrated NAM-based testing strategy for screening data-poor compounds prioritized by Health Canada’s New Substances Assessment and Control Bureau. Human lymphoblastoid TK6 cells were exposed to 3 control and 10 data-poor substances, using a 6-point concentration range. Gene expression profiling was conducted using the targeted TempO-SeqTM assay, and the TGx-DDI classifier was applied to the dataset. Classifications were compared with those based on the MicroFlow® and MultiFlow® assays. Benchmark Concentration (BMC) modeling was used for potency ranking. The results of the integrated hazard calls indicate that five of the data-poor compounds were genotoxic in vitro, causing DNA damage via a clastogenic MoA, and one via a pan-genotoxic MoA. Two compounds were likely irrelevant positives in the MN test; two are considered possibly genotoxic causing DNA damage via an ambiguous MoA. BMC modeling revealed nearly identical potency rankings for each assay. This ranking was maintained when all endpoint BMCs were converted into a single score using the Toxicological Prioritization (ToxPi) approach. Overall, this study contributes to the establishment of a modernized approach for effective genotoxicity assessment and chemical prioritization for further regulatory scrutiny. We conclude that the integration of TGx-DDI, MicroFlow®, and MultiFlow® endpoints is an effective NAM-based strategy for genotoxicity assessment of data-poor compounds.

Dataset Information

Fast Delayed Emission in New Pyridazine-Based Compounds.

Publications

Fast Delayed Emission in New Pyridazine-Based Compounds.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets